Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06263361

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma (PCNSL): Integration of Advanced MRI Patterns and Fluorescein Sodium Fluorescence

Status
Recruiting
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. The aim of this study is to evaluate the MRI imaging characteristics of the peritumoral area (PTA) and to correlate this information to pathological findings.

Detailed description

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. It is a relatively rare disorder, accounting for only 3% of all primary brain tumors but due to its anatomical localization represents an important clinical and diagnostic challenge in onco-hematology. different MRI patterns of the peritumoral area (PTA) might correlate with different histopathological sensitivity regarding diagnostic potential out of contrast-enhanced region (CER). Improvements in the understanding of PTA diagnostic potentials is of great help in diagnosing patients with deep-seated lesions, who would otherwise be not eligible for stereotactic biopsy and therefore for a consequent adequate treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRI imagingTo characterize the peritumoral area in PCNLs through the use of advanced MRI sequences.
DIAGNOSTIC_TESTCerebral biopsyTo evaluate the predictive value of sodium fluorescence to confirm ex-vivo the diagnostic tumor tissue prior to histopathological examination.

Timeline

Start date
2021-10-01
Primary completion
2028-12-31
Completion
2029-12-31
First posted
2024-02-16
Last updated
2025-06-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06263361. Inclusion in this directory is not an endorsement.